4610108702!INFLUENZA VIRUS VAC

Contract Award won by GLAXOSMITHKLINE, LLC
No current value reported
RecipientGLAXOSMITHKLINE, LLC UEI FRHTPHMZMX47
Award IDSPE2DP24D0005
Award amountNo current value reported
Award type—
Awarding agencyDepartment of Defense — Defense Logistics Agency
NAICS325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
PSC6505
Set-asideUnrestricted
Start dateMar 13, 2024
End date—
Place of performance—
Record updatedMay 21, 2024

View the official award record

More awards won by GLAXOSMITHKLINE, LLC

:COVID-19: SOTROVIMAB MONOCLONAL ANDTIBODIES
Department of Defense · $1,596,901,996 · Nov 15, 2021
GLAXOSMITHKLINE ADJUVANT AS03
Department of Defense · $346,055,756 · Jul 30, 2020
:COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB
Department of Defense · $279,862,800 · Sep 24, 2021
RELENZA (ZANAMIVIR) ROTADISK, 5MG
Department of Health and Human Services · $45,499,950 · Sep 30, 2025
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.
Department of Health and Human Services · $22,877,697 · Sep 14, 2022

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids